Influence of doxorubicin inclusion into phospholipid nanoformulation on its antitumor activity in mice: increased efficiency for resistant tumor model

• Veröffentlicht in: Experimental Oncology
• Datum: 2012
• Hauptverfasser: Zykova, M.G., Medvedeva, N.V., Torkhovskava, T.I., Tikhonova, E.G., Prozorovskii, V.N., Zakharova, T.S., Ipatova, O.M.
• Format: Artikel
• Sprache: English
• Veröffentlicht: Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України 2012
• Schlagworte: Original contributions
• Online Zugang: https://nasplib.isofts.kiev.ua/handle/123456789/139869
• Назва журналу: Digital Library of Periodicals of National Academy of Sciences of Ukraine
• Zitieren: Influence of doxorubicin inclusion into phospholipid nanoformulation on its antitumor activity in mice: increased efficiency for resistant tumor model / M.G. Zykova, N.V. Medvedeva, T.I. Torkhovskaya, E.G. Tikhonova, V.N. Prozorovskii, T.S. Zakharova, O.M. Ipatova // Experimental Oncology. — 2012. — Т. 34, № 4. — С. 323-326. — Бібліогр.: 26 назв. — англ.

Aim: The new formulation of doxorubicin on the base of phospholipid nanoparticles (particle size <30 nm) is elaborated in the Institute of Biomedical Chemistry (Russian Academy of Medical Sciences) on the base of plant phospholipids. The aim of study is to investigate an antitumor effect of this...